Dr Robert Feldman

Biography

, Chief Executive Officer Dr Feldman has an invaluable combination of business, medical and research experience spanning two decades. A qualified medical practitioner, he obtained his medical degree in London, his PhD in the Netherlands, has worked at Harvard Medical School and held clinical and academic positions at Imperial College, London. Dr Feldman is a successful serial life science entrepreneur, having founded the UK vaccine company Microscience and antimicrobial company Vmax. He later went on to become CEO of hepatitis C therapeutic company, RioTech before establishing the European operations for the New York based company Paramount Biosciences, LLC. As Entrepreneur in Residence for Imperial Innovations, London, Dr Feldman also co-founded the spin-out company, Indigix. In 2010, he moved to New Zealand as Executive Director of Pacific Channel and subsequently founded his own life science consulting company, Line 5. During his extensive and varied career, Dr Feldman has developed a breadth of medical, research and commercial expertise encompassing therapeutics, devices, diagnostics. He has also gained a deep understanding of business and product development, fundraising, venture and governance. During Dr Feldman’s time in the UK and New Zealand, he has engaged in business development activities globally, including concluding successful licensing deals in Europe, USA, Australia, Russia, South Korea and New Zealand.

Research Interest

 =